glp-1 medications and alcohol A new clinical trial supported by the National Institutes of Health (NIH) found that a medication commonly used for weight loss, such as semaglutide, may also help reduce heavy drinking in individuals GLP-1 receptor agonists for the

It does not hit the basket evenly The headline is that these shoppers buy less

Individuals across the nation have filed claims alleging that Ozempic has caused severe and debilitating health complications, including delayed gastric emptying, stomach paralysis, chronic gastrointestinal distress, and other life-altering conditions

Once a niche topic in endocrinology, this naturally occurring gut hormone has been thrust into the global spotlight, heralded as a revolutionary tool in the management of type 2 diabetes and, most notably, weight loss

Transparent pricing: Clear costs without the usual supplement markups